4 / 9
E u r o p e a n C o n g r e s s o n
Vaccines & Vaccination
and Gynecologic Oncology
Journal of Clinical Immunology and Allergy
ISSN: 2471-304X
O c t o b e r 2 6 - 2 7 , 2 0 1 8
B u d a p e s t , H u n g a r y
Vaccines & Vaccination and Gynecologic Oncology 2018
Page 20
Biography
Kathleen Hefferon has received her PhD from the Department
of Medical Biophysics, University of Toronto and completed her
Postdoctoral Fellowship at Cornell University. She has published
multiple research papers, chapters and reviews, and has written
three books. She is the Fulbright Canada Research Chair of
Global Food Security and has been a Visiting Professor at the
University of Toronto over the past years. Her research interests
include virus expression vectors, food security agricultural
biotechnology and global health.
klh22@cornell.eduPlant virus nanoparticles: new
applications for developing countries
Kathleen Hefferon
Cornell University, USA
Kathleen Hefferon, Journal of Clinical Immunology and Allergy, Volume: 4
DOI: 10.21767/2471-304X-C2-004
F
or over two decades now, plants have been explored for their potential to
act as production Platforms for biopharmaceuticals such as vaccines and
monoclonal antibodies. Without a doubt, the development of plant viruses as
expression vectors for pharmaceutical production have played an integral role in
the emergence of plants as inexpensive and facile systems for the generation of
therapeutic proteins. More recently, plant viruses have been designed as non-toxic
nanoparticles which can target a variety of cancers and thus empower the immune
system to slow or even reverse tumor progression. The following presentation
describes the employment of plant virus expression vectors for the treatment of
some of the most challenging diseases known today. The presentation concludes
with a projection of the multiple avenues by which virus nanoparticles could
impact developing countries.
Euro Vaccines 2018